Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene

Molecular and Cellular Proteomics

Volumn 6, Issue 8, 2007, Pages 1318-1330

  Wishart, Thomas M ^a   Paterson, Janet M ^a   Short, Duncan M ^b   Meredith, Sara ^a   Robertson, Kevin A ^b   Sutherland, Calum ^c   Cousin, Michael A ^a   Dutia, Mayank B ^a   Gillingwater, Thomas H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING MITOCHONDRIAL CARRIER PROTEIN 1; DIHYDROPYRIMIDINASE RELATED PROTEIN 2; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; MITOCHONDRIAL PROTEIN; MITOFILIN; RAB PROTEIN; UBIQUITIN ACTIVATING ENZYME 4B; UBIQUITIN ACTIVATING ENZYME E1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMINO ACID SEQUENCE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; FEMALE; MOUSE; NERVE DEGENERATION; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SYNAPSE; SYNAPTOSOME;

ANIMALS; FEMALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; NERVE TISSUE PROTEINS; PROTEOMICS; SYNAPSES; WALLERIAN DEGENERATION;

MUS; WALLERIA;

EID: 34548386721     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600457-MCP200     Document Type: Article

References (68)

1. Coleman, M. (2005) Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889-898
2. Wishart, T. M., Parson, S. H., and Gillingwater, T. H. (2006) Synaptic vulnerability in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 65, 733-739
3. Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., and Gordon, S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1, 27-33
4. s protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann. Neurol. 50, 773-779
5. s mutant and Ube4b/Nmnat transgenic mice. J. Physiol. 543, 739-755
6. Ferri, A., Sanes, J. R., Coleman, M. P., Cunningham, J. M., and Kato, A. C. (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13, 669-673
7. s mutant mice. J. Cereb. Blood Flow Metab. 24, 62-66
8. Sajadi, A., Schneider, B. L., and Aebischer, P. (2004) Wids-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr. Biol. 14, 326-330
9. s, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128, 405-416
10. Mack, T. G., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., Fernando, F. S., Tarlton, A., Andressen, C., Addicks, K., Magni, G., Ribchester, R. R., Perry, V. H., and Coleman, M. P. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4, 1199-1206
11. s) with improved preservation of neuromuscular synapses. Eur. J. Neurosci. 21, 271-277
12. MacDonald, J. M., Beach, M. G., Porpiglia, E., Sheehan, A. E., Watts, R. J., and Freeman, M. R. (2006) The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron. 50, 869-881
13. Conforti, L., Tarlton, A., Mack, T. G., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., and Coleman, M. P. (2000) A Ufd2/D4Cole1 e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl. Acad. Sci. U. S. A. 97, 11377-11382
14. Fang, C., Bernardes-Silva, M., Coleman, M. P., and Perry, V. H. (2005) The cellular distribution of the Wlds chimeric protein and its constituent proteins in the CNS. Neuroscience 135, 1107-1118
15. Deckwerth, T. L., and Johnson, E. M. (1994) Neurites can remain viable after the destruction of the neuronal soma by programmed cell death. Dev. Biol. 165, 63-72
16. Adalbert, R., Nogradi, A., Szabo, A., and Coleman, M. P. (2006) The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy. Eur. J. Neurosci. 24, 2163-2168
17. s mice. J. Neurosci. Res. 84, 1799-1807
18. Coleman, M. P., and Perry, V. H. (2002) Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25, 532-537
19. Coleman, M. P., and Ribchester, R. R. (2004) Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system. Curr. Drug Targets CNS Neurol. Disord. 3, 227-238
20. Laser, H., Conforti, L., Morreale, G., Mack, T. G., Heyer, M., Haley, J. E., Wishart, T. M., Beirowski, B., Walker, S. A., Haase, G., Celik, A., Adalbert, R., Wagner, D., Grumme, D., Ribchester, R. R., Plomann, M., and Coleman, M. P. (2006) The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol. Biol. Cell 17, 1075-1084
21. Araki, T., Sasaki, Y., and Milbrandt, J. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305, 1010-1013
22. Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M. W., and He, Z. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell Biol. 170, 349-355
23. Sasaki, Y., Araki, T., and Milbrandt, J. (2006) Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 25, 8484-8491
24. + and axon degeneration revisited: Nmnat1 cannot substitute for WldS to delay Wallerian degeneration. Cell. Death Differ. 14, 116-127
25. s expression and the independence of the activity of Nmnat1. Neurosci. Lett. 411, 228-232
26. Gillingwater, T. H., Wishart, T. M., Chen, P. E., Haley, J. E., Robertson, K., MacDonald, S. H., Middleton, S., Wawrowski, K., Shipston, M. J., Melmed, S., Wyllie, D. J., Skehel, P. A., Coleman, M. P., and Ribchester, R. R. (2006) The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum. Mol. Genet. 15, 625-635
27. s mice after cortical lesion. Brain 129, 1546-1556
28. Paterson, J. M., Short, D., Flatman, P. W., Seckl, J. R., Aitken, A., and Dutia, M. B. (2006) Changes in protein expression in the medial vestibular nuclei during vestibular compensation. J. Physiol. 575, 777-788
29. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
30. Grant, S. N. G. (2006) The synapse proteome and phosphoproteome: a new paradigm for synapse biology. Biochem. Soc. Trans. 34, 59-63
31. Shimizu, S., Narita, M., and Tsujimoto, Y. (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487
32. Salvat, C., Jariel-Encontre, I., Acquaviva, C., Omura, S., and Piechaczyk, M. (1998) Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts. Oncogene 17, 327-337
33. Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y., and Tsujimoto, Y. (2001) Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J. Cell Biol. 152, 237-250
34. Mattson, M. P., and Duan, W. (1999) "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 152-166
35. Yamashita, A., Maeda, K., and Maeda, Y. (2003) Crystal structure of CapZ: structural basis for actin filament barbed end capping. EMBO J. 22, 1529-1538
36. Buettner, R., Papoutsoglou, G., Scemes, E., Spray, D. C., and Dermietzel, R. (2000) Evidence for secretory pathway localization of a voltage-dependent anion channel isoform. Proc. Natl. Acad. Sci. U. S. A. 97, 3201-3206
37. + myeloma cells accompanied by the increased expression of VDAC1. Oncogene 25, 419-429
38. John, G. B., Shang, Y., Li, L., Renken, C., Mannella, C. A., Selker, J. M. L., Rangell, L., Bennett, M. J., and Zha, J. (2005) The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol. Biol. Cell 16, 1543-1554
39. Ikegami, K., and Koike, T. (2003) Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 122, 617-626
40. Ferreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, A., Piemonte, F., Tozzi, G., Gaeta, L., Casari, G., Ballabio, A., and Rugarli, E. I. (2004) Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Investig. 113, 231-242
41. Sievers, C., Platt, N., Perry, V. H., Coleman, M. P., and Conforti, L. (2003) Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci. Res. 46, 161-169
42. Berliocchi, L., Fava, E., Leist, M., Horvat, V., Dinsdale, D., Read, D., and Nicotera, P. (2005) Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis. J. Cell Biol. 168 607-618
43. Ly, C. V., and Verstreken, P. (2006) Mitochondria at the synapse. Neuroscientist 12, 291-299
44. Kwong, J. Q., Beal, M. F., and Manfredi, G. (2006) The role of mitochondria in inherited neurodegenerative diseases. J. Neurochem. 97, 1659-1675
45. Andrews, H. E., Nichols, P. P., Bates, D., and Turnbull, D. M. (2005) Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis. Med. Hypotheses 64, 669-677
46. Martin, L. J. (2006) Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 65, 1103-1110
47. Samsam, M., Mi, W., Wessig, C., Zielasek, J., Toyka, K. V., Coleman, M. P., and Martini, R. (2003) The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23, 2833-2839
48. 2+ overload than non-synaptic mitochondria. J. Biol. Chem. 281, 11658-11668
49. Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R., Hoopfer, E., Mitchison, T., Luo, L., and He, Z. (2003) Involvement of the ubiquitin-proteasome system in the early stages of Wallerian degeneration. Neuron 39, 217-225
50. Korhonen, L., and Lindholm, D. (2004) The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. J. Cell Biol. 165, 27-30
51. Yi, J. J., and Ehlers, M. D. (2005) Ubiquitin and protein turnover in synapse function. Neuron 47, 629-632
52. Upadhya, S. C., Ding, L., Smith, T. K., and Hegde, A. N. (2006) Differential regulation of proteasome activity in the nucleus and synaptic terminals. Neurochem. Int. 48, 296-305
53. Watts, R. J., Hoopfer, E. D., and Luo, L. (2003) Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38, 871-885
54. 2+ signals to neuronal mitochondria. J. Biol. Chem. 281, 1039-1047
55. Baker, M. A., Lane, D. J., Ly, J. D., DePinto, V., and Lawen, A. (2004) VDAC1 is a transplasma membrane NADH-ferricyanide reductase. J. Biol. Chem. 279, 4811-4819
56. Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., Markesbery, W. R., and Butterfield, D. A. (2006) Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol. Aging 27, 1564-1576
57. Selkoe, D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
58. Perluigi, M., Fai Poon, H., Hensley, K., Pierce, W. M., Klein, J. B., Calabrese, V., De Marco, C., and Butterfield, D. A. (2005) Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice - a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 38, 960-968
59. Nakata, K., Ujike, H., Sakai, A., Takaki, M., Imamura, T., Tanaka, Y., and Kuroda, S. (2003) The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biol. Psychiatry 53, 571-576
60. Boyd-Kimball, D., Castegna, A., Sultana, R., Poon, H. F., Petroze, R., Lynn, B. C., Klein, J. B., and Butterfield, D. A. (2005) Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res. 1044, 206-215
61. Verdier, Y., Huszar, E., Penke, B., Penke, Z., Woffendin, G., Scigelova, M., Fulop, L., Szucs, M., Medzihradszky, K., and Janaky, T. (2005) Identification of synaptic plasma membrane proteins co-precipitated with fibrillar β-amyloid peptide. J. Neurochem. 94, 617-628
62. Castegna, A., Thongboonkerd, V., Klein, J., Lynn, B. C., Wang, Y. L., Osaka, H., Wade, K., and Butterfield, D. A. (2004) Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. J. Neurochem. 88, 1540-1546
63. Lassle, M., Blatch, G. L., Kundra, V., Takatori, T., and Zetter, B. R. (1997) Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J. Biol. Chem. 272, 1876-1884
64. Zanata, S. M., Lopes, M. H., Mercadante, A. F., Hah, G. N., Chiarini, L. B., Nomizo, R., Freitas, A. R., Cabral, A. L, Lee, K. S., Juliano, M. A., de Oliveira, E., Jachieri, S. G., Burlingame, A., Huang, L, Linden, R., Brentani, R. R., and Martins, V. R. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316
65. Lopes, M. H., Hajj, G. N., Muras, A. G., Mancini, G. L., Castro, R. M., Ribeiro, K. C., Brentani, R. R., Linden, R., and Martins, V. R. (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25, 11330-11339
66. Sakudo, A., Lee, D. C., Li, S., Nakamura, T., Matsumoto, Y., Saeki, K., Itohara, S., Ikuta, K., and Onodera, T. (2005) PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 328, 14-19
67. Zou, H., McGarry, T. J., Bernal, T., and Kirschner, M. W. (1999) Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418-422
68. Wada, I., Rindress, D., Cameron, P. H., Ou, W. J., Doherty, J. J., Louvard, D., Bell, A. W., Dignard, D., Thomas, D. Y., and Bergeron, J. J. (1991) SSR α and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266, 19599-19610